Description: Court is in session and you are the jury! Follow along as challenging aspects of actuarial professionalism are explored in a court-like setting. Deliberate based on what you already know from your own experience as well as based on what you learn in this session and then deliver your verdict accordingly. Who says learning about actuarial professionalism can't also be fun?

Description: This article contains a condensed summary and excerpt from the fourth white paper in the Commercial Health Care: What’s Next? series.

Description: Voluntary health insurance coverage options are described including hospital indemnity, accident plans, disability insurance, and critical illness policies.

Description: With the 2017 pricing season nearly complete for commercial health care, and two of the 3R risk mitigation programs in the rear view mirror, what should we expect going forward in the commercial health care markets? This session will focus on coming ACA legislation impacts, market morbidity, consolidation of carriers, strategy, tactics and other concerns.

Description: Insurance commissioners and deputy insurance commissioners will discuss current topics including health care reform, life insurance issues, risks in the major medical markets, voluntary products and other topics.

Description: This article contains a condensed summary and excerpts from a recent white paper regarding the Individual Mandate.

Description: This article discusses the potential characteristics of health care reform and the associated impact on small insurance companies.

Description: A new initiative, Commercial Health Care: What’s Next, will focus on education and research for health actuaries regarding issues that remain with the ACA.

Description: The Health Section's strategic initiative entitled Commercial Health Care: What’s Next? focuses on health care reform. This article contains a summary

Description: Insurance commissioners and/or deputy commissioners will discuss a variety of current topics including health care reform, risks in the major medical markets, voluntary products and other topics. At the conclusion of the session, attendees will be able to identify issues that are on the mind of the regulatory agencies and the different approaches used across the country.